Global CRISPR & Cas9 Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global CRISPR & Cas9 market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The Global Info Research report includes an overview of the development of the CRISPR & Cas9 industry chain, the market status of Biotechnology Companies (Genome Editing, Genetic Engineering), Pharmaceutical Companies (Genome Editing, Genetic Engineering), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CRISPR & Cas9.
Regionally, the report analyzes the CRISPR & Cas9 markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CRISPR & Cas9 market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CRISPR & Cas9 market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CRISPR & Cas9 industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Genome Editing, Genetic Engineering).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CRISPR & Cas9 market.
Regional Analysis: The report involves examining the CRISPR & Cas9 market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CRISPR & Cas9 market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CRISPR & Cas9:
Company Analysis: Report covers individual CRISPR & Cas9 players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CRISPR & Cas9 This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biotechnology Companies, Pharmaceutical Companies).
Technology Analysis: Report covers specific technologies relevant to CRISPR & Cas9. It assesses the current state, advancements, and potential future developments in CRISPR & Cas9 areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CRISPR & Cas9 market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CRISPR & Cas9 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe CRISPR & Cas9 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR & Cas9, with revenue, gross margin and global market share of CRISPR & Cas9 from 2019 to 2024.
Chapter 3, the CRISPR & Cas9 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRISPR & Cas9 market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR & Cas9.
Chapter 13, to describe CRISPR & Cas9 research findings and conclusion.
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The Global Info Research report includes an overview of the development of the CRISPR & Cas9 industry chain, the market status of Biotechnology Companies (Genome Editing, Genetic Engineering), Pharmaceutical Companies (Genome Editing, Genetic Engineering), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CRISPR & Cas9.
Regionally, the report analyzes the CRISPR & Cas9 markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CRISPR & Cas9 market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CRISPR & Cas9 market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CRISPR & Cas9 industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Genome Editing, Genetic Engineering).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CRISPR & Cas9 market.
Regional Analysis: The report involves examining the CRISPR & Cas9 market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CRISPR & Cas9 market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CRISPR & Cas9:
Company Analysis: Report covers individual CRISPR & Cas9 players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CRISPR & Cas9 This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biotechnology Companies, Pharmaceutical Companies).
Technology Analysis: Report covers specific technologies relevant to CRISPR & Cas9. It assesses the current state, advancements, and potential future developments in CRISPR & Cas9 areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CRISPR & Cas9 market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CRISPR & Cas9 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Genome Editing
- Genetic Engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
- Caribou Biosciences
- Integrated DNA Technologies(IDT)
- CRISPR Therapeutics
- Merck
- Mirus Bio
- Editas Medicine
- Takara Bio
- Thermo Fisher Scientific
- Horizon Discovery Group
- Intellia Therapeutics
- Agilent Technologies
- Cellecta
- GenScript
- GeneCopoeia
- Synthego
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe CRISPR & Cas9 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR & Cas9, with revenue, gross margin and global market share of CRISPR & Cas9 from 2019 to 2024.
Chapter 3, the CRISPR & Cas9 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRISPR & Cas9 market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR & Cas9.
Chapter 13, to describe CRISPR & Cas9 research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of CRISPR & Cas9
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CRISPR & Cas9 by Type
1.3.1 Overview: Global CRISPR & Cas9 Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global CRISPR & Cas9 Consumption Value Market Share by Type in 2023
1.3.3 Genome Editing
1.3.4 Genetic Engineering
1.3.5 gRNA Database/Gene Librar
1.3.6 CRISPR Plasmid
1.3.7 Human Stem Cells
1.3.8 Genetically Modified Organisms/Crops
1.3.9 Cell Line Engineering
1.4 Global CRISPR & Cas9 Market by Application
1.4.1 Overview: Global CRISPR & Cas9 Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Biotechnology Companies
1.4.3 Pharmaceutical Companies
1.4.4 Academic Institutes
1.4.5 Research and Development Institutes
1.5 Global CRISPR & Cas9 Market Size & Forecast
1.6 Global CRISPR & Cas9 Market Size and Forecast by Region
1.6.1 Global CRISPR & Cas9 Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global CRISPR & Cas9 Market Size by Region, (2019-2030)
1.6.3 North America CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.4 Europe CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.6 South America CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa CRISPR & Cas9 Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Caribou Biosciences
2.1.1 Caribou Biosciences Details
2.1.2 Caribou Biosciences Major Business
2.1.3 Caribou Biosciences CRISPR & Cas9 Product and Solutions
2.1.4 Caribou Biosciences CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Caribou Biosciences Recent Developments and Future Plans
2.2 Integrated DNA Technologies(IDT)
2.2.1 Integrated DNA Technologies(IDT) Details
2.2.2 Integrated DNA Technologies(IDT) Major Business
2.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Product and Solutions
2.2.4 Integrated DNA Technologies(IDT) CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Integrated DNA Technologies(IDT) Recent Developments and Future Plans
2.3 CRISPR Therapeutics
2.3.1 CRISPR Therapeutics Details
2.3.2 CRISPR Therapeutics Major Business
2.3.3 CRISPR Therapeutics CRISPR & Cas9 Product and Solutions
2.3.4 CRISPR Therapeutics CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CRISPR Therapeutics Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck CRISPR & Cas9 Product and Solutions
2.4.4 Merck CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments and Future Plans
2.5 Mirus Bio
2.5.1 Mirus Bio Details
2.5.2 Mirus Bio Major Business
2.5.3 Mirus Bio CRISPR & Cas9 Product and Solutions
2.5.4 Mirus Bio CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Mirus Bio Recent Developments and Future Plans
2.6 Editas Medicine
2.6.1 Editas Medicine Details
2.6.2 Editas Medicine Major Business
2.6.3 Editas Medicine CRISPR & Cas9 Product and Solutions
2.6.4 Editas Medicine CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Editas Medicine Recent Developments and Future Plans
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio CRISPR & Cas9 Product and Solutions
2.7.4 Takara Bio CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Takara Bio Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific CRISPR & Cas9 Product and Solutions
2.8.4 Thermo Fisher Scientific CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 Horizon Discovery Group
2.9.1 Horizon Discovery Group Details
2.9.2 Horizon Discovery Group Major Business
2.9.3 Horizon Discovery Group CRISPR & Cas9 Product and Solutions
2.9.4 Horizon Discovery Group CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Horizon Discovery Group Recent Developments and Future Plans
2.10 Intellia Therapeutics
2.10.1 Intellia Therapeutics Details
2.10.2 Intellia Therapeutics Major Business
2.10.3 Intellia Therapeutics CRISPR & Cas9 Product and Solutions
2.10.4 Intellia Therapeutics CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Intellia Therapeutics Recent Developments and Future Plans
2.11 Agilent Technologies
2.11.1 Agilent Technologies Details
2.11.2 Agilent Technologies Major Business
2.11.3 Agilent Technologies CRISPR & Cas9 Product and Solutions
2.11.4 Agilent Technologies CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Agilent Technologies Recent Developments and Future Plans
2.12 Cellecta
2.12.1 Cellecta Details
2.12.2 Cellecta Major Business
2.12.3 Cellecta CRISPR & Cas9 Product and Solutions
2.12.4 Cellecta CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Cellecta Recent Developments and Future Plans
2.13 GenScript
2.13.1 GenScript Details
2.13.2 GenScript Major Business
2.13.3 GenScript CRISPR & Cas9 Product and Solutions
2.13.4 GenScript CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 GenScript Recent Developments and Future Plans
2.14 GeneCopoeia
2.14.1 GeneCopoeia Details
2.14.2 GeneCopoeia Major Business
2.14.3 GeneCopoeia CRISPR & Cas9 Product and Solutions
2.14.4 GeneCopoeia CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GeneCopoeia Recent Developments and Future Plans
2.15 Synthego
2.15.1 Synthego Details
2.15.2 Synthego Major Business
2.15.3 Synthego CRISPR & Cas9 Product and Solutions
2.15.4 Synthego CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Synthego Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global CRISPR & Cas9 Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of CRISPR & Cas9 by Company Revenue
3.2.2 Top 3 CRISPR & Cas9 Players Market Share in 2023
3.2.3 Top 6 CRISPR & Cas9 Players Market Share in 2023
3.3 CRISPR & Cas9 Market: Overall Company Footprint Analysis
3.3.1 CRISPR & Cas9 Market: Region Footprint
3.3.2 CRISPR & Cas9 Market: Company Product Type Footprint
3.3.3 CRISPR & Cas9 Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global CRISPR & Cas9 Consumption Value and Market Share by Type (2019-2024)
4.2 Global CRISPR & Cas9 Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global CRISPR & Cas9 Consumption Value Market Share by Application (2019-2024)
5.2 Global CRISPR & Cas9 Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America CRISPR & Cas9 Consumption Value by Type (2019-2030)
6.2 North America CRISPR & Cas9 Consumption Value by Application (2019-2030)
6.3 North America CRISPR & Cas9 Market Size by Country
6.3.1 North America CRISPR & Cas9 Consumption Value by Country (2019-2030)
6.3.2 United States CRISPR & Cas9 Market Size and Forecast (2019-2030)
6.3.3 Canada CRISPR & Cas9 Market Size and Forecast (2019-2030)
6.3.4 Mexico CRISPR & Cas9 Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe CRISPR & Cas9 Consumption Value by Type (2019-2030)
7.2 Europe CRISPR & Cas9 Consumption Value by Application (2019-2030)
7.3 Europe CRISPR & Cas9 Market Size by Country
7.3.1 Europe CRISPR & Cas9 Consumption Value by Country (2019-2030)
7.3.2 Germany CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.3 France CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.4 United Kingdom CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.5 Russia CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.6 Italy CRISPR & Cas9 Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific CRISPR & Cas9 Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CRISPR & Cas9 Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CRISPR & Cas9 Market Size by Region
8.3.1 Asia-Pacific CRISPR & Cas9 Consumption Value by Region (2019-2030)
8.3.2 China CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.3 Japan CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.4 South Korea CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.5 India CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.7 Australia CRISPR & Cas9 Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America CRISPR & Cas9 Consumption Value by Type (2019-2030)
9.2 South America CRISPR & Cas9 Consumption Value by Application (2019-2030)
9.3 South America CRISPR & Cas9 Market Size by Country
9.3.1 South America CRISPR & Cas9 Consumption Value by Country (2019-2030)
9.3.2 Brazil CRISPR & Cas9 Market Size and Forecast (2019-2030)
9.3.3 Argentina CRISPR & Cas9 Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa CRISPR & Cas9 Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CRISPR & Cas9 Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CRISPR & Cas9 Market Size by Country
10.3.1 Middle East & Africa CRISPR & Cas9 Consumption Value by Country (2019-2030)
10.3.2 Turkey CRISPR & Cas9 Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia CRISPR & Cas9 Market Size and Forecast (2019-2030)
10.3.4 UAE CRISPR & Cas9 Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 CRISPR & Cas9 Market Drivers
11.2 CRISPR & Cas9 Market Restraints
11.3 CRISPR & Cas9 Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 CRISPR & Cas9 Industry Chain
12.2 CRISPR & Cas9 Upstream Analysis
12.3 CRISPR & Cas9 Midstream Analysis
12.4 CRISPR & Cas9 Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of CRISPR & Cas9
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CRISPR & Cas9 by Type
1.3.1 Overview: Global CRISPR & Cas9 Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global CRISPR & Cas9 Consumption Value Market Share by Type in 2023
1.3.3 Genome Editing
1.3.4 Genetic Engineering
1.3.5 gRNA Database/Gene Librar
1.3.6 CRISPR Plasmid
1.3.7 Human Stem Cells
1.3.8 Genetically Modified Organisms/Crops
1.3.9 Cell Line Engineering
1.4 Global CRISPR & Cas9 Market by Application
1.4.1 Overview: Global CRISPR & Cas9 Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Biotechnology Companies
1.4.3 Pharmaceutical Companies
1.4.4 Academic Institutes
1.4.5 Research and Development Institutes
1.5 Global CRISPR & Cas9 Market Size & Forecast
1.6 Global CRISPR & Cas9 Market Size and Forecast by Region
1.6.1 Global CRISPR & Cas9 Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global CRISPR & Cas9 Market Size by Region, (2019-2030)
1.6.3 North America CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.4 Europe CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.6 South America CRISPR & Cas9 Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa CRISPR & Cas9 Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Caribou Biosciences
2.1.1 Caribou Biosciences Details
2.1.2 Caribou Biosciences Major Business
2.1.3 Caribou Biosciences CRISPR & Cas9 Product and Solutions
2.1.4 Caribou Biosciences CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Caribou Biosciences Recent Developments and Future Plans
2.2 Integrated DNA Technologies(IDT)
2.2.1 Integrated DNA Technologies(IDT) Details
2.2.2 Integrated DNA Technologies(IDT) Major Business
2.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Product and Solutions
2.2.4 Integrated DNA Technologies(IDT) CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Integrated DNA Technologies(IDT) Recent Developments and Future Plans
2.3 CRISPR Therapeutics
2.3.1 CRISPR Therapeutics Details
2.3.2 CRISPR Therapeutics Major Business
2.3.3 CRISPR Therapeutics CRISPR & Cas9 Product and Solutions
2.3.4 CRISPR Therapeutics CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CRISPR Therapeutics Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck CRISPR & Cas9 Product and Solutions
2.4.4 Merck CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments and Future Plans
2.5 Mirus Bio
2.5.1 Mirus Bio Details
2.5.2 Mirus Bio Major Business
2.5.3 Mirus Bio CRISPR & Cas9 Product and Solutions
2.5.4 Mirus Bio CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Mirus Bio Recent Developments and Future Plans
2.6 Editas Medicine
2.6.1 Editas Medicine Details
2.6.2 Editas Medicine Major Business
2.6.3 Editas Medicine CRISPR & Cas9 Product and Solutions
2.6.4 Editas Medicine CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Editas Medicine Recent Developments and Future Plans
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio CRISPR & Cas9 Product and Solutions
2.7.4 Takara Bio CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Takara Bio Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific CRISPR & Cas9 Product and Solutions
2.8.4 Thermo Fisher Scientific CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 Horizon Discovery Group
2.9.1 Horizon Discovery Group Details
2.9.2 Horizon Discovery Group Major Business
2.9.3 Horizon Discovery Group CRISPR & Cas9 Product and Solutions
2.9.4 Horizon Discovery Group CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Horizon Discovery Group Recent Developments and Future Plans
2.10 Intellia Therapeutics
2.10.1 Intellia Therapeutics Details
2.10.2 Intellia Therapeutics Major Business
2.10.3 Intellia Therapeutics CRISPR & Cas9 Product and Solutions
2.10.4 Intellia Therapeutics CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Intellia Therapeutics Recent Developments and Future Plans
2.11 Agilent Technologies
2.11.1 Agilent Technologies Details
2.11.2 Agilent Technologies Major Business
2.11.3 Agilent Technologies CRISPR & Cas9 Product and Solutions
2.11.4 Agilent Technologies CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Agilent Technologies Recent Developments and Future Plans
2.12 Cellecta
2.12.1 Cellecta Details
2.12.2 Cellecta Major Business
2.12.3 Cellecta CRISPR & Cas9 Product and Solutions
2.12.4 Cellecta CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Cellecta Recent Developments and Future Plans
2.13 GenScript
2.13.1 GenScript Details
2.13.2 GenScript Major Business
2.13.3 GenScript CRISPR & Cas9 Product and Solutions
2.13.4 GenScript CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 GenScript Recent Developments and Future Plans
2.14 GeneCopoeia
2.14.1 GeneCopoeia Details
2.14.2 GeneCopoeia Major Business
2.14.3 GeneCopoeia CRISPR & Cas9 Product and Solutions
2.14.4 GeneCopoeia CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GeneCopoeia Recent Developments and Future Plans
2.15 Synthego
2.15.1 Synthego Details
2.15.2 Synthego Major Business
2.15.3 Synthego CRISPR & Cas9 Product and Solutions
2.15.4 Synthego CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Synthego Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global CRISPR & Cas9 Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of CRISPR & Cas9 by Company Revenue
3.2.2 Top 3 CRISPR & Cas9 Players Market Share in 2023
3.2.3 Top 6 CRISPR & Cas9 Players Market Share in 2023
3.3 CRISPR & Cas9 Market: Overall Company Footprint Analysis
3.3.1 CRISPR & Cas9 Market: Region Footprint
3.3.2 CRISPR & Cas9 Market: Company Product Type Footprint
3.3.3 CRISPR & Cas9 Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global CRISPR & Cas9 Consumption Value and Market Share by Type (2019-2024)
4.2 Global CRISPR & Cas9 Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global CRISPR & Cas9 Consumption Value Market Share by Application (2019-2024)
5.2 Global CRISPR & Cas9 Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America CRISPR & Cas9 Consumption Value by Type (2019-2030)
6.2 North America CRISPR & Cas9 Consumption Value by Application (2019-2030)
6.3 North America CRISPR & Cas9 Market Size by Country
6.3.1 North America CRISPR & Cas9 Consumption Value by Country (2019-2030)
6.3.2 United States CRISPR & Cas9 Market Size and Forecast (2019-2030)
6.3.3 Canada CRISPR & Cas9 Market Size and Forecast (2019-2030)
6.3.4 Mexico CRISPR & Cas9 Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe CRISPR & Cas9 Consumption Value by Type (2019-2030)
7.2 Europe CRISPR & Cas9 Consumption Value by Application (2019-2030)
7.3 Europe CRISPR & Cas9 Market Size by Country
7.3.1 Europe CRISPR & Cas9 Consumption Value by Country (2019-2030)
7.3.2 Germany CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.3 France CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.4 United Kingdom CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.5 Russia CRISPR & Cas9 Market Size and Forecast (2019-2030)
7.3.6 Italy CRISPR & Cas9 Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific CRISPR & Cas9 Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CRISPR & Cas9 Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CRISPR & Cas9 Market Size by Region
8.3.1 Asia-Pacific CRISPR & Cas9 Consumption Value by Region (2019-2030)
8.3.2 China CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.3 Japan CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.4 South Korea CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.5 India CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia CRISPR & Cas9 Market Size and Forecast (2019-2030)
8.3.7 Australia CRISPR & Cas9 Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America CRISPR & Cas9 Consumption Value by Type (2019-2030)
9.2 South America CRISPR & Cas9 Consumption Value by Application (2019-2030)
9.3 South America CRISPR & Cas9 Market Size by Country
9.3.1 South America CRISPR & Cas9 Consumption Value by Country (2019-2030)
9.3.2 Brazil CRISPR & Cas9 Market Size and Forecast (2019-2030)
9.3.3 Argentina CRISPR & Cas9 Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa CRISPR & Cas9 Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CRISPR & Cas9 Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CRISPR & Cas9 Market Size by Country
10.3.1 Middle East & Africa CRISPR & Cas9 Consumption Value by Country (2019-2030)
10.3.2 Turkey CRISPR & Cas9 Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia CRISPR & Cas9 Market Size and Forecast (2019-2030)
10.3.4 UAE CRISPR & Cas9 Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 CRISPR & Cas9 Market Drivers
11.2 CRISPR & Cas9 Market Restraints
11.3 CRISPR & Cas9 Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 CRISPR & Cas9 Industry Chain
12.2 CRISPR & Cas9 Upstream Analysis
12.3 CRISPR & Cas9 Midstream Analysis
12.4 CRISPR & Cas9 Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
